每年專案
指紋
查看啟用 婦產學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
-
-
透過子宮頸拭子之 DNA 甲基化生物標記來評估與偵測卵巢腫瘤的風險(3/3)
Wen, K.-C. (PI)
8/1/26 → 7/31/27
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse
Chen, C. C., Hsiao, K. Y., Lu, S. C., Bai, C. H., Wen, K. C. & Wang, Y. H., 2026, 於: Journal of Lower Genital Tract Disease. 30, 2, p. 100-109 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Bidirectional associations between smart device use and body mass index among children aged 3 to 5 years: a longitudinal study
Chakranon, P., Huang, J. P., Au, H. K., Chiou, H., Lin, C. L., Chen, Y. Y., Mao, S. P., Kim, P., Hsu, H. W. & Chen, Y. H., 12月 2026, 於: International Journal of Behavioral Nutrition and Physical Activity. 23, 1, 18.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Decellularized Testicular Extracellular Matrix Scaffolds Support Mature Spermatogenesis: Impact of Donor Age and Transplantation Microenvironment
Hou, J. H., Tseng, H., Xiao, B. S., Wang, Y. C., Weng, S. M. & Chen, C. H., 6月 2026, 於: International journal of molecular sciences. 27, 11, 4828.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 連結會在新分頁中打開 引文 斯高帕斯（Scopus）
資料集
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
資料集: Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
資料集: Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
資料集: Dataset